Y
Yung Yi Cheng
Researcher at University of North Carolina at Chapel Hill
Publications - 49
Citations - 621
Yung Yi Cheng is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Mechanism of action & Prodrug. The author has an hindex of 11, co-authored 46 publications receiving 374 citations. Previous affiliations of Yung Yi Cheng include National Yang-Ming University & China Medical University (Taiwan).
Papers
More filters
Journal ArticleDOI
Concurrent administration of anticancer chemotherapy drug and herbal medicine on the perspective of pharmacokinetics
TL;DR: Information is provided based on pharmacokinetic evidence for healthcare professionals to use in educating patients about the risks of the concomitant use of various remedies to provide information based on drug-drug interactions.
Journal ArticleDOI
Pharmacokinetics and Biodistribution of the Illegal Food Colorant Rhodamine B in Rats
Yung Yi Cheng,Tung Hu Tsai +1 more
TL;DR: A simple and sensitive high-performance liquid chromatography method with fluorescence detection for the quantitative detection of rhodamine B in the plasma and organs of rats and to estimate its pharmacokinetics and biodistribution is developed.
Journal ArticleDOI
Development of anti‐influenza agents from natural products
Zhi‐Jun Zhang,Susan L. Morris-Natschke,Yung Yi Cheng,Kuo Hsiung Lee,Kuo Hsiung Lee,Rong‐Tao Li +5 more
TL;DR: This comprehensive review of chemical ingredients, crude extracts, and TCM prescriptions with anti‐influenza activity reported during the period of 2010–September 2019 is reviewed to provide a promising alternative candidate for further anti‐Influenza drug development.
Journal ArticleDOI
Nanocarrier-Mediated Immunogenic Chemotherapy for Triple Negative Breast Cancer
TL;DR: Taking together, 17-AAG liposomes could remodel the immunosuppressive microenvironment of triple negative breast cancer and facilitate the checkpoint blockade immunotherapy.
Journal ArticleDOI
Synthesis and in vitro anticancer activity of 6,7-methylenedioxy (or 5-hydroxy-6-methoxy)-2-(substituted selenophenyl)quinolin-4-one analogs.
Chien-Ting Chen,Mei Hua Hsu,Yung Yi Cheng,Chin Yu Liu,Li Chen Chou,Li-Jiau Huang,Tian Shung Wu,Tian Shung Wu,Xiaoming Yang,Kuo Hsiung Lee,Kuo Hsiung Lee,Sheng-Chu Kuo +11 more
TL;DR: 6,7-Methylenedioxy (or 5-hydroxy-6-methoxy)-2-(substituted selenophenyl)quinolin-4-ones and their isosteric compounds were synthesized and evaluated for anticancer activity, finding 4d to be the most promising anticancer agent.